AU2003207089A1 - Preparation for topical administration - Google Patents

Preparation for topical administration

Info

Publication number
AU2003207089A1
AU2003207089A1 AU2003207089A AU2003207089A AU2003207089A1 AU 2003207089 A1 AU2003207089 A1 AU 2003207089A1 AU 2003207089 A AU2003207089 A AU 2003207089A AU 2003207089 A AU2003207089 A AU 2003207089A AU 2003207089 A1 AU2003207089 A1 AU 2003207089A1
Authority
AU
Australia
Prior art keywords
preparation
topical administration
topical
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003207089A
Inventor
Nobuyuki Goya
Yasutaka Igari
Shigeo Yanai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AU2003207089A1 publication Critical patent/AU2003207089A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003207089A 2003-02-14 2003-02-14 Preparation for topical administration Abandoned AU2003207089A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2003/001519 WO2004071533A1 (en) 2003-02-14 2003-02-14 Preparation for topical administration

Publications (1)

Publication Number Publication Date
AU2003207089A1 true AU2003207089A1 (en) 2004-09-06

Family

ID=32866111

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003207089A Abandoned AU2003207089A1 (en) 2003-02-14 2003-02-14 Preparation for topical administration

Country Status (2)

Country Link
AU (1) AU2003207089A1 (en)
WO (1) WO2004071533A1 (en)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2222625A1 (en) * 1995-06-07 1996-12-19 Merck & Co., Inc. Treatment and prevention of prostatic disease
US6294517B1 (en) * 1996-02-02 2001-09-25 Nitromed, Inc. Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use
CA2305394C (en) * 1997-10-28 2006-12-12 Vivus, Incorporated Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
US6228864B1 (en) * 1997-10-28 2001-05-08 Vivus, Inc. Administration of 5-HT receptor agonists and antagonists, to treat premature ejaculation
US6153614A (en) * 1998-07-16 2000-11-28 Abbott Laboratories Piperazinyl pyrimidine dione compounds selective for adrenoceptors
ES2297934T3 (en) * 1998-08-03 2008-05-01 Ronald E. Wheeler PROSTATIC FORMULA.
HUP0104493A3 (en) * 1998-09-30 2002-12-28 Takeda Pharmaceutical Drugs for improving vesical excretory strength
IL144729A0 (en) * 1999-02-05 2002-06-30 Cipla Ltd Topical sprays
CH693625A5 (en) * 1999-02-18 2003-11-28 Inpharma Sa Pharmaceutical compositions containing compounds of promoter activity of absorption of active ingredients.
IL141235A (en) * 2000-02-09 2012-04-30 Novartis Int Pharm Ltd Combined use of an alpha-adrenoceptor antagonist and a muscarinic antagonist in the manufacture of a medicament for the treatment of benign prostatic hyperplasia
HUP0303944A3 (en) * 2001-04-13 2005-06-28 Yamanouchi Pharma Co Ltd Novel use of pyrimidinyl phenylethylene sulfonamide derivative

Also Published As

Publication number Publication date
WO2004071533A1 (en) 2004-08-26

Similar Documents

Publication Publication Date Title
AU2003268087A1 (en) Liposomal gemcitabine compositions for better drug delivery
EP1643990B8 (en) Metronidazole-based green tinted topical pharmaceutical composition
AU2003298738A1 (en) Liposomal formulations
AU2003291103A1 (en) Pharmaceutical composition
AU2003901813A0 (en) Pharmaceutical derivatives
AU2003242239A1 (en) Cosmetic preparation
AU2003250372A1 (en) Pharmaceutical composition
EP1648364A4 (en) Pharmaceutical compositions for topical application
AU2003221699A1 (en) Pharmaceutical preparation for taste masking
AU2003221577A1 (en) Entitlements administration
AU2003284460A1 (en) Medicinal composition
AU2003291642A1 (en) Pyrazoloazepine compounds as pharmaceutical agents
AU2003280799A1 (en) Medicinal composition
AU2003264443A1 (en) Preparation for external use
AU2003243972A1 (en) External preparation for improving coital function
AU2003289718A1 (en) Cosmetic preparation
AU2003255954A1 (en) Substituted glycine derivatives for use as medicaments
AU2003207089A1 (en) Preparation for topical administration
AU2003289011A1 (en) Composition for topical anesthesia
AU2003280678A1 (en) Medicinal composition
AU2003244092A1 (en) 1ss-METHYLCARBAPENEM DERIVATIVE FOR ORAL ADMINISTRATION
AU2003211235A1 (en) Sustained-release ointment for topical administration
AUPS188302A0 (en) Pharmaceutical composition
AU2003220855A1 (en) Medicinal antitumor composition
AU2003901530A0 (en) Topical formulation

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase